BACKGROUND: Recently, conflicting reports have been published on the potential role of genetic variants in the alpha-T catenin gene (VR22; CTNNA3) on the risk for Alzheimer's disease. In these papers, evidence for association is mostly observed in multiplex families with Alzheimer's disease, whereas case-control samples of sporadic Alzheimer's disease are predominantly negative. METHODS: After sequencing VR22 in multiplex families with Alzheimer's disease linked to chromosome 10q21, we identified a novel non-synonymous (Ser596Asn; rs4548513) single nucleotide polymorphism (SNP). This and four non-coding SNPs were assessed in two independent samples of families with Alzheimer's disease, one with 1439 subjects from 437 multiplex families with Alzheimer's disease and the other with 489 subjects from 217 discordant sibships. RESULTS: A weak association with the Ser596Asn SNP in the multiplex sample, predominantly in families with late-onset Alzheimer's disease (p = 0.02), was observed. However, this association does not seem to contribute substantially to the chromosome 10 Alzheimer's disease linkage signal that we and others have reported previously. No evidence was found of association with any of the four additional SNPs tested in the multiplex families with Alzheimer's disease. Finally, the Ser596Asn change was not associated with the risk for Alzheimer's disease in the independent discordant sibship sample. CONCLUSIONS: This is the first study to report evidence of an association between a potentially functional, non-synonymous SNP in VR22 and the risk for Alzheimer's disease. As the underlying effects are probably small, and are only seen in families with multiple affected members, the population-wide significance of this finding remains to be determined.
BACKGROUND: Recently, conflicting reports have been published on the potential role of genetic variants in the alpha-T catenin gene (VR22; CTNNA3) on the risk for Alzheimer's disease. In these papers, evidence for association is mostly observed in multiplex families with Alzheimer's disease, whereas case-control samples of sporadic Alzheimer's disease are predominantly negative. METHODS: After sequencing VR22 in multiplex families with Alzheimer's disease linked to chromosome 10q21, we identified a novel non-synonymous (Ser596Asn; rs4548513) single nucleotide polymorphism (SNP). This and four non-coding SNPs were assessed in two independent samples of families with Alzheimer's disease, one with 1439 subjects from 437 multiplex families with Alzheimer's disease and the other with 489 subjects from 217 discordant sibships. RESULTS: A weak association with the Ser596Asn SNP in the multiplex sample, predominantly in families with late-onset Alzheimer's disease (p = 0.02), was observed. However, this association does not seem to contribute substantially to the chromosome 10 Alzheimer's disease linkage signal that we and others have reported previously. No evidence was found of association with any of the four additional SNPs tested in the multiplex families with Alzheimer's disease. Finally, the Ser596Asn change was not associated with the risk for Alzheimer's disease in the independent discordant sibship sample. CONCLUSIONS: This is the first study to report evidence of an association between a potentially functional, non-synonymous SNP in VR22 and the risk for Alzheimer's disease. As the underlying effects are probably small, and are only seen in families with multiple affected members, the population-wide significance of this finding remains to be determined.
Authors: Deborah Blacker; Lars Bertram; Aleister J Saunders; Thomas J Moscarillo; Marilyn S Albert; Howard Wiener; Rodney T Perry; Julianne S Collins; Lindy E Harrell; Rodney C P Go; Amy Mahoney; Terri Beaty; M Danielle Fallin; Dimitrios Avramopoulos; Gary A Chase; Marshal F Folstein; Melvin G McInnis; Susan S Bassett; Kimberly J Doheny; Elizabeth W Pugh; Rudolph E Tanzi Journal: Hum Mol Genet Date: 2003-01-01 Impact factor: 6.150
Authors: E R Martin; P G Bronson; Y-J Li; N Wall; R-H Chung; D E Schmechel; G Small; P-T Xu; J Bartlett; N Schnetz-Boutaud; J L Haines; J R Gilbert; M A Pericak-Vance Journal: J Med Genet Date: 2005-10 Impact factor: 6.318
Authors: L Bertram; D Blacker; K Mullin; D Keeney; J Jones; S Basu; S Yhu; M G McInnis; R C Go; K Vekrellis; D J Selkoe; A J Saunders; R E Tanzi Journal: Science Date: 2000-12-22 Impact factor: 47.728
Authors: A Myers; P Holmans; H Marshall; J Kwon; D Meyer; D Ramic; S Shears; J Booth; F W DeVrieze; R Crook; M Hamshere; R Abraham; N Tunstall; F Rice; S Carty; S Lillystone; P Kehoe; V Rudrasingham; L Jones; S Lovestone; J Perez-Tur; J Williams; M J Owen; J Hardy; A M Goate Journal: Science Date: 2000-12-22 Impact factor: 47.728
Authors: N Ertekin-Taner; N Graff-Radford; L H Younkin; C Eckman; M Baker; J Adamson; J Ronald; J Blangero; M Hutton; S G Younkin Journal: Science Date: 2000-12-22 Impact factor: 47.728
Authors: Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi Journal: N Engl J Med Date: 2005-03-03 Impact factor: 91.245
Authors: Nilüfer Ertekin-Taner; James Ronald; Hideaki Asahara; Linda Younkin; Maria Hella; Shushant Jain; Eugene Gnida; Samuel Younkin; Daniel Fadale; Yasumasa Ohyagi; Adam Singleton; Leah Scanlin; Mariza de Andrade; Ronald Petersen; Neill Graff-Radford; Michael Hutton; Steven Younkin Journal: Hum Mol Genet Date: 2003-10-14 Impact factor: 6.150
Authors: Victoria Busby; Steven Goossens; Petra Nowotny; Gillian Hamilton; Scott Smemo; Denise Harold; Dragana Turic; Luke Jehu; Amanda Myers; Meredith Womick; Daniel Woo; Danielle Compton; Lisa M Doil; Kristina M Tacey; Kit F Lau; Safa Al-Saraj; Richard Killick; Stuart Pickering-Brown; Pamela Moore; Paul Hollingworth; Nicola Archer; Catherine Foy; Sarah Walter; Corrine Lendon; Takeshi Iwatsubo; John C Morris; Joanne Norton; David Mann; Barbara Janssens; John Hardy; Michael O'Donovan; Lesley Jones; Julie Williams; Peter Holmans; Michael J Owen; Andrew Grupe; John Powell; Jolanda van Hengel; Alison Goate; Frans Van Roy; Simon Lovestone Journal: Neuromolecular Med Date: 2004 Impact factor: 3.843
Authors: Oliver S P Davis; Lee M Butcher; Sophia J Docherty; Emma L Meaburn; Charles J C Curtis; Michael A Simpson; Leonard C Schalkwyk; Robert Plomin Journal: Behav Genet Date: 2010-03-21 Impact factor: 2.805
Authors: Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines Journal: Genet Epidemiol Date: 2008-04 Impact factor: 2.135
Authors: Todd L Edwards; Margaret Pericak-Vance; Johnny R Gilbert; Jonathan L Haines; Eden R Martin; Marylyn D Ritchie Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-07-05 Impact factor: 3.568
Authors: M Ryan Dickson; Jian Li; Howard W Wiener; Rodney T Perry; Deborah Blacker; Susan S Bassett; Rodney C P Go Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-09-05 Impact factor: 3.568
Authors: Sarah Lincoln; Mariet Allen; Claire L Cox; Louise P Walker; Kimberly Malphrus; Yushi Qiu; Thuy Nguyen; Christopher Rowley; Naomi Kouri; Julia Crook; V Shane Pankratz; Samuel Younkin; Linda Younkin; Minerva Carrasquillo; Fanggeng Zou; Samer O Abdul-Hay; Wolfdieter Springer; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Zbigniew K Wszolek; Jada M Lewis; Dennis Dickson; Neill R Graff-Radford; Ronald C Petersen; Elizabeth Eckman; Steven G Younkin; Nilüfer Ertekin-Taner Journal: PLoS One Date: 2013-06-04 Impact factor: 3.240